WHO ICTRP trial
The PALM-study (Placebo, Losartan, Low sodium & Moxonidine after PE)
EUCTR2014-002524-27-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-002524-27-NL |
|---|---|
| Public title | The PALM-study (Placebo, Losartan, Low sodium & Moxonidine after PE) |
| Scientific title | A randomized, placebo-controlled, double blind, 4-period, cross-over trial, to study blood pressure lowering effects of losartan, Moxonidine and Low sodium diet in former pre-eclamptic women - PALM study |
| Primary sponsor | University Medical Center Utrecht |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Netherlands |
| Conditions | Post Partum Hypertension after preeclamptic pregnancy;Therapeutic area: Body processes [G] - Physiological processes [G07] |
| Interventions | Trade Name: Losartankalium Pharmaceutical Form: Capsule Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Trade Name: Moxonidine Pharmaceutical Form: Capsule Pharmaceutical form of the placebo… |
| Registration date | Dec 18, 2014 |
| Secondary IDs | 14-285;NL49102.041.14 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: